Related stories
Integra LifeSciences Reports Third-Quarter 2026 Revenue of $411.18 Million
Net income was $14.85 million and diluted EPS was $0.19, compared with a $5.4 million net loss and a $0.07 per-share loss a year earlier. Revenue was $402.06 million in the prior-y
M impact | EQUITY | Oct 23, 2026, 08:11 PM UTC
Integra LifeSciences Reports Quarterly Results
Integra LifeSciences reported results for the quarter ended September 30. The supplied text contains no financial figures.
M impact | EQUITY | Oct 21, 2026, 01:31 PM UTC
Integra LifeSciences Q3 Revenue Slightly Misses Estimates on Flood Damage
M impact | EQUITY | Oct 21, 2026, 10:10 AM UTC
Integra LifeSciences Sees Fourth-Quarter Revenue at $413M-$433M
M impact | EARNINGS | Oct 21, 2026, 10:02 AM UTC
Integra LifeSciences Sees 2026 Adjusted EPS of $2.30-$2.40
M impact | EARNINGS | Oct 21, 2026, 10:02 AM UTC
Fed's Hammack Says Do Not Take Anchored Inflation Expectations For Granted, With Businesses Planning Price Increases Beyond Any Rise In Input Costs A Sign Of Inflationary Mindset Taking Hold; Fed Officials Have A Responsibility To Explain Their Decisions; It Is Important To Spell Out Reaction Function So Businesses And Households Can Plan Effectively; If The Public Understands Where The Fed Is Heading, It Can Limit Market Volatility, Avoid Mistakes; A Reaction Function Is Not The Same As Committ
Fed's Hammack Says Do Not Take Anchored Inflation Expectations For Granted, With Businesses Planning Price Increases Beyond Any Rise In Input Costs A Sign Of Inflationary Mindset T
H impact | LIVE | Oct 12, 2026, 05:08 PM UTC